鴨用藥品和疫苗市場：按類型、應用和地區分類

Duck Medicine and Vaccines Market, By Type (Medicine, Vaccines), By Application (Farm, Government), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

出版日期: 2026年03月06日 | 出版商:

Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，鴨藥和疫苗市場規模將達到25.6億美元，到2033年將達到42.65億美元。預計從2026年到2033年，該市場將以7.6%的複合年成長率成長。

分析範圍		分析詳情
基準年	2025	市場規模（2026 年）	25.6億美元
效能數據	2020-2024	預測期	2026-2033
預測期（2026-2033 年）複合年成長率	7.60%	預計金額（2033 年）	42.65億美元

養鴨業在世界成長最快的產業之一——家禽業中扮演著至關重要的角色。鴨病是一個主要問題，因為它們會影響小規模和無地養殖戶的經濟收入。鴨子是農村生計的重要組成部分，因為它們能提供穩定的肉蛋供應。預防疫情爆發最重要的措施之一是保持鴨子的健康。與其他影響鴨子的疾病相比，病毒已被報告對鴨子的生產力造成毀滅性的影響。鴨子中最常見的疾病是大腸桿菌感染疾病，這通常是由於養殖場衛生條件不佳造成的。鴨子對黴菌毒素，尤其是黃麴毒素，極為敏感。黃麴毒素是一種由黃麴菌產生的有毒致癌性代謝物，主要損害肝臟。這是一個根深蒂固卻常常被忽略的問題。毒素吸附劑，即添加到家禽飼料中以微量存在的物質，用於中和或去活化有害化學物質、黴菌毒素或內毒素，應定期添加到鴨飼料中。適當的疫苗接種和治療有助於預防鴨子疾病。

市場動態

預計科學家加強對鴨病疫苗的研發力度將推動預測期內市場成長。例如，2020年9月，喀拉拉邦獸醫與動物科學大學（KVASU）曼努蒂分校獸醫微生物學系的科學家們研發出一種針對鴨類致病性線蟲病（一種導致鴨類大量死亡的細菌性疾病）的疫苗。該大學致力於推廣永續且盈利的畜牧養殖系統。線蟲病在鴨類的死亡率為5%至75%，在5週齡以下的雛鴨中死亡率超過50%。

本報告的主要特點

本報告指出了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
本節根據以下參數介紹全球鴨藥和疫苗市場的主要企業概況：公司概況、產品系列、主要亮點、財務表現和策略。
本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、產品線更新、市場擴張和行銷策略做出明智的決策。
《全球鴨藥和疫苗市場》報告面向該行業的眾多相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過分析全球鴨藥和疫苗市場中使用的各種策略矩陣來促進決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太地區
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第7章競爭情勢

Boehringer Ingelheim International GmbH.
Ceva
YEBIO BIOENGINEERING CO., LTD
NAVETCO
Shangqiu Meilan Biological Engineering Co.,Ltd
Merck & Co., Inc.
EGAVET
Bioveta, as
Jilin Zhengye Biological Products company limited
Harbin Pharmaceutical Group Bio-vaccine Co. Ltd.

第8章

分析方法
關於 Coherent Market Insights

簡介目錄

Product Code: CMI4956

Duck Medicine And Vaccines Market is estimated to be valued at USD 2,560 Mn in 2026 and is expected to reach USD 4,265 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7.6% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 2,560 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	7.60%	2033 Value Projection:	USD 4,265 Mn

Duck farming plays a vital role in the poultry industry, which is one of the fastest-growing sectors in the world. Duck diseases are a major cause of concern because they can affect finances of small and landless farmers. Ducks are important to rural livelihoods because they provide a steady supply of meat and eggs. One of the most important measures to prevent outbreaks is to maintain the health of the ducks. Viruses have been reported to have more devastating consequences for duck productivity than other diseases that affect ducks. The most prevalent disease in ducks is Escherichia coli due to poor farm hygiene. Ducks are highly vulnerable to mycotoxins, notably aflatoxin, a toxic and carcinogenic metabolite of Aspergillus flavus that primarily affects the liver. This is a persistent issue that isn't always recognized. A toxin binder, which is a substance added to poultry feed in minute quantities to neutralize or immobilize harmful chemicals, mycotoxins or endotoxins should be included in duck diets on a regular basis. Proper vaccination and treatment can help prevent diseases in ducks.

Market Dynamics

The increasing research and development activities by scientists to develop vaccines for the diseases of ducks are expected to drive the market growth during the forecast period. For instance, in September 2020, scientists at the Department of Veterinary Microbiology, Kerala Veterinary and Animal Sciences University (KVASU), Mannuthy, a university aiming to promote sustainable and profitable animal production systems, developed a vaccine for Riemerellosis, a bacterial disease that causes significant mortality in ducks. In ducks, Riemerellosis causes 5-75 percent mortality and more than 50 percent mortality in ducklings under the age of five weeks.

Key features of the study

This report provides an in-depth analysis of the global duck medicine and vaccines market, and provides market size (USD million) and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global duck medicine and vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Boehringer Ingelheim International GmbH., Ceva, YEBIO BIOENGINEERING CO., LTD., NAVETCO, Shangqiu Meilan Biological Engineering Co.,Ltd., Merck & Co., Inc., EGAVET, Bioveta, a.s., Jilin Zhengye Biological Products company limited, and Harbin Pharmaceutical Group Bio-vaccine Co. Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global duck medicine and vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global duck medicine and vaccines market

Market Segmentation

By Type Insights (Revenue, USD Mn, 2020 - 2033)
- Medicine
- Vaccines
By Application Insights (Revenue, USD Mn, 2020 - 2033)
- Farm
- Government
By Region Insights (Revenue, USD Mn, 2020 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
Key Players
- Boehringer Ingelheim International GmbH
- Ceva
- YEBIO BIOENGINEERING CO., LTD.
- NAVETCO
- Shangqiu Meilan Biological Engineering Co. Ltd.
- Merck & Co., Inc.
- EGAVET
- Bioveta, a.s.
- Jilin Zhengye Biological Products company limited
- Harbin Pharmaceutical Group Bio-vaccine Co. Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Application
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Market Trends
Regulatory Scenario
Reimbursement Scenario
Technology Landscape
Product Launches
PEST Analysis

4. Global Duck Medicine and Vaccines Market, By Type, 2020 - 2033, (USD Mn)

Overview
- Market Share Analysis, 2020 and 2033 (%)
- Y-o-Y Growth Analysis, 2020 - 2033
- Segment Trends
Medicine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2033, (USD Mn)
Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2033, (USD Mn)

5. Global Duck Medicine and Vaccines Market, By Application, 2020 - 2033, (USD Mn)

Overview
- Market Share Analysis, 2020 and 2033 (%)
- Y-o-Y Growth Analysis, 2020 - 2033
- Segment Trends
Farm
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
Government
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)

6. Global Duck Medicine and Vaccines Market, By Region, 2020 - 2033, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2020 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2020-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2033, (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2033, (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2033, (USD Mn)
  - UK
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2033, (USD Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2033, (USD Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2033, (USD Mn)
  - North Africa
  - Central Africa
  - South Africa

7. Competitive Landscape

Boehringer Ingelheim International GmbH.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Ceva
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
YEBIO BIOENGINEERING CO., LTD
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
NAVETCO
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Shangqiu Meilan Biological Engineering Co.,Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
EGAVET
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bioveta, a.s.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Jilin Zhengye Biological Products company limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Harbin Pharmaceutical Group Bio-vaccine Co. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies